Geneos Wealth Management’s Vanguard Materials ETF VAW Stock Holding History

Geneos Wealth Management’s Portfolio VAW Stock Details VAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4K	Hold	89	–	–	﹤0.01%	1792
2026 Q1	$20.1K	Hold	89	–	–	﹤0.01%	1767
2025 Q4	$18.5K	Hold	89	–	–	﹤0.01%	1755
2025 Q3	$18.2K	Hold	89	–	–	﹤0.01%	1753
2025 Q2	$17.3K	Buy	89 +22	+33%	+$4.12K	﹤0.01%	2095
2025 Q1	$12.7K	Hold	67	–	–	﹤0.01%	2158
2024 Q4	$12.6K	Hold	67	–	–	﹤0.01%	1955
2024 Q3	$14.2K	Hold	67	–	–	﹤0.01%	1695
2024 Q2	$12.9K	Sell	67 -1	-1%	-$199	﹤0.01%	1475
2024 Q1	$13.9K	Buy	68 +1	+1%	+$190	﹤0.01%	1461
2023 Q4	$12.7K	Hold	67	–	–	﹤0.01%	1483
2023 Q3	$11.6K	Hold	67	–	–	﹤0.01%	1526
2023 Q2	$12.2K	Sell	67 -62	-48%	-$10.8K	﹤0.01%	1521
2023 Q1	$22.9K	Hold	129	–	–	﹤0.01%	1300
2022 Q4	$22K	Hold	129	–	–	﹤0.01%	1313
2022 Q3	$19K	Sell	129 -906	-88%	-$149K	﹤0.01%	1346
2022 Q2	$166K	Sell	1,035 -7	-0.7%	-$1.28K	0.01%	817
2022 Q1	$202K	Buy	1,042 +170	+19%	+$31.8K	0.01%	802
2021 Q4	$171K	Buy	872 +2	+0.2%	+$377	0.01%	936
2021 Q3	$153K	Sell	870 -91	-9%	-$16.5K	0.01%	979
2021 Q2	$175K	Sell	961 -39	-4%	-$7.2K	0.01%	909
2021 Q1	$181K	Buy	1,000 +39	+4%	+$6.42K	0.01%	1010
2020 Q4	$167K	Buy	961 +299	+45%	+$44K	0.01%	905
2020 Q3	$87K	Sell	662 -319	-33%	-$42.3K	﹤0.01%	1000
2020 Q2	$114K	Sell	981 -10	-1%	-$1.12K	0.01%	859
2020 Q1	$93K	Sell	991 -40	-4%	-$4.75K	0.01%	859
2019 Q4	$137K	Sell	1,031 -29	-3%	-$3.74K	0.01%	832
2019 Q3	$133K	Buy	1,060 +6	+0.6%	+$753	0.01%	798
2019 Q2	$135K	Buy	1,054 +58	+6%	+$7.2K	0.01%	800
2019 Q1	$122K	Buy	996 +1	+0.1%	+$120	0.01%	795
2018 Q4	$109K	Sell	995 -35	-3%	-$4.15K	0.01%	813
2018 Q3	$135K	Buy	1,030 +1	+0.1%	+$134	0.01%	785
2018 Q2	$135K	Hold	1,029	–	–	0.01%	690
2018 Q1	$132K	Buy	1,029 +1	+0.1%	+$137	0.01%	653
2017 Q4	$140K	Buy	1,028 +1	+0.1%	+$133	0.01%	642
2017 Q3	$132K	Sell	1,027 -13	-1%	-$1.62K	0.01%	630
2017 Q2	$126K	Buy	1,040 +14	+1%	+$1.68K	0.01%	625
2017 Q1	$122K	Hold	1,026	–	–	0.01%	607
2016 Q4	$115K	Hold	1,026	–	–	0.02%	578
2016 Q3	$109K	Sell	1,026 -14	-1%	-$1.5K	0.01%	581
2016 Q2	$106K	Buy	1,040 +26	+3%	+$2.66K	0.02%	576
2016 Q1	$100K	Buy	+1,014	New	+$91K	0.02%	581

Other funds holding VAW

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCMIO

Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.65B AUM 17.84% 1-Year Est. Return

Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

PCH

PGIM Custom Harvest Newark, New Jersey $7.98B AUM 28.14% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geneos Wealth Management's VAW Position: Q2 2026 in Review

Geneos Wealth Management held its Vanguard Materials ETF (VAW) position steady in Q2 2026 at 89 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Geneos Wealth Management first reported a position in VAW in Q1 2016 and has held it in 42 quarters since. The position peaked at $202K in Q1 2022. 426 funds tracked by Wall St. Rank hold VAW as of Q2 2026.

Geneos Wealth Management held 89 shares of Vanguard Materials ETF worth $20.4K as of Q2 2026.
Geneos Wealth Management left its Vanguard Materials ETF share count unchanged in Q2 2026.
Vanguard Materials ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1792 holding.
Geneos Wealth Management first reported a position in Vanguard Materials ETF in Q1 2016 and has held it in 42 quarters since.
Geneos Wealth Management's Vanguard Materials ETF position peaked at $202K in Q1 2022.
426 funds tracked by Wall St. Rank held Vanguard Materials ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.